Citrome, Leslie http://orcid.org/0000-0002-6098-9266
Risinger, Robert
Rajachandran, Lavanya
Robison, Heather
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
https://doi.org/10.1007/s12325-022-02274-3
Documents that mention this clinical trial
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
https://doi.org/10.1007/s12325-022-02274-3
Funding for this research was provided by:
BioXcel Therapeutics
Article History
Received: 14 June 2022
Accepted: 14 July 2022
First Online: 24 August 2022
Change Date: 31 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12325-022-02350-8